Glucose metabolism in pediatric traumatic brain injury

Mayumi L Prins1

  • 1UCLA Department of Neurosurgery, 300 Stein Plaza, Suite 532, PO Box 957039, Los Angeles, CA, 90024-7039, USA. mprins@mednet.ucla.edu.

Insights

Pediatric traumatic brain injury (TBI) disrupts glucose metabolism. Understanding age-related changes in pediatric TBI glucose metabolism is crucial for optimizing patient support and recovery.

Area of Science:

  • Neuroscience
  • Pediatric Medicine
  • Biochemistry

Background:

  • Traumatic brain injury (TBI) is a leading cause of death and disability in children.
  • Pediatric TBI presents unique challenges due to ongoing cerebral maturation and age-specific injury mechanisms.
  • Existing research on glucose metabolism in pediatric TBI is limited, highlighting a critical knowledge gap.

Purpose of the Study:

  • To review normal changes in cerebral glucose metabolism across pediatric developmental phases.
  • To examine how TBI impacts glucose metabolism in children.
  • To discuss optimal substrate management and glycemic control strategies for pediatric TBI.

Main Methods:

  • Literature review of studies on pediatric TBI and cerebral glucose metabolism.
  • Analysis of age-related differences in pathophysiology and recovery profiles post-TBI.
  • Examination of evidence regarding glucose processing disruptions after TBI.

Main Results:

  • TBI significantly disrupts the biochemical processing of glucose for energy in the pediatric brain.
  • Age-related variations in cerebral maturation influence TBI's impact on metabolism.
  • Optimal substrate utilization for pediatric TBI management remains an open question.

Conclusions:

  • Understanding age-specific glucose metabolism alterations post-TBI is vital for pediatric neurocritical care.
  • Further research is needed to establish optimal metabolic support strategies for injured young brains.
  • Tailoring interventions based on developmental stage can improve outcomes for pediatric TBI patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.7K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K